논문KCI 등재
Letter regarding “Evidence-based hyponatremia management in liver disease”
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
참고문헌 (10)
- Ji Young Ryu, "Evidence-based hyponatremia management in liver disease", Clinical and Molecular Hepatology, 29(4), pp.924~944 (2023), 대한간학회
- Guevara M, "Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis : a prospective study with timedependent analysis", Am J Gastroenterol, 104, pp.1382~1389 (2009)
- Cárdenas A, "Hyponatremia influences the outcome of patients with acute-on-chronic liver failure : an analysis of the CANONIC study", Crit Care, 18, pp.700~ (2014)
- Adrogué HJ, "Diagnosis and management of hyponatremia : A review", JAMA, 328, pp.280~291 (2022)
- Ruzek KA, "Early diagnosis of central pontine myelinolysis with diffusion-weighted imaging", AJNR Am J Neuroradiol, 25, pp.210~213 (2004)
- Moriwaka F, "MR imaging of pontine and extrapontine myelinolysis", J Comput Assist Tomogr, 12, pp.446~449 (1988)
- Malhotra K, "Central pontine myelinolysis with meticulous correction of hyponatraemia in chronic alcoholics", BMJ Case Rep, 2013, pp.bcr2013009970~ (2013)
- Dervisoglu E, "Diffusion magnetic resonance imaging may provide prognostic information in osmotic demyelination syndrome : report of a case", Acta Radiol, 47, pp.208~212 (2006)
- Chu K, "Diffusion-weighted MR findings of central pontine and extrapontine myelinolysis", Acta Neurol Scand, 104, pp.385~388 (2001)
- Neely SA, "New oligodendrocytes exhibit more abundant and accurate myelin regeneration than those that survive demyelination", Nat Neurosci, 25, pp.415~420 (2022)
관련 논문AI추천
Correspondence on Letter regarding “Evidence-based hyponatremia management in liver disease”백선하, Ji Young Ryu, Sejoong Kim대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제4호Erratum : Correspondence on Letter regarding “Evidence-based hyponatremia management in liver disease”백선하, Ji Young Ryu, Sejoong Kim대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제1호Correspondence on Editorial regarding “Baveno- VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”Giulia Tosetti, Massimo Primignani, Sanchit Sharma, Xiaolong Qi, Yu Jun Wong대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제1호Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”Do Seon Song, Jin Mo Yang, U Im Chang대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제1호Correspondence to editorial on “Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)”Chuan Liu, Gao-Jun Teng, Hong You, Ling Yang, Xiaolong Qi대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Reply to Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”Hyung Joon Yim, Tae Hyung Kim, Young Kul Jung대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제1호
이 간행물의 다른 논문 (22건)
Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernityJoon Ho Moon, 김원, Gi-Ae Kimpp. 831-843Waiting for the changes after the adoption of steatotic liver disease전대원, Eileen L. Yoonpp. 844-850Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapyTakako Inoue, Yasuhito Tanaka, Takehisa Watanabepp. 851-868Safety considerations for withdrawal of nucleos(t)ide analogues in patients with chronic hepatitis B: First, do no harmYao-Chun Hsu, Jia-Horng Kao, Cheng-Hao Tsengpp. 869-890Hepatorenal syndrome: Current concepts and future perspectivesChan-Young Jung, Jai Won Changpp. 891-908
